{"disease":{"id":"metastatic-and-locally-advanced-nrg1-rearranged-malignancies","name":"metastatic and locally advanced nrg1 rearranged malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04410653","title":"Afatinib in Advanced NRG1-Rearranged Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"German Cancer Research Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}